Bio-Rad Laboratories Inc (BIO)

Debt-to-assets ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	1,199,100	1,198,710	1,198,380	1,198,000	1,197,700	1,197,270	1,196,940	1,196,740	10,514	10,600	10,779	10,901	12,258	12,241	12,200	12,205	13,579	437,808	437,680	437,600
Total assets	US$ in thousands	12,299,100	11,895,900	11,978,200	13,667,400	13,501,700	12,058,500	12,682,100	14,373,700	17,799,400	19,953,400	15,117,600	13,933,200	12,972,600	12,020,900	10,097,300	8,684,360	8,008,860	7,177,100	7,646,900	6,862,900
Debt-to-assets ratio		0.10	0.10	0.10	0.09	0.09	0.10	0.09	0.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06	0.06	0.06

December 31, 2023 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $1,199,100K ÷ $12,299,100K
= 0.10

The debt-to-assets ratio for Bio-Rad Laboratories Inc. has been relatively stable over the past eight quarters, ranging from 0.08 to 0.10. This ratio indicates the proportion of the company's assets that are financed through debt. A lower ratio typically suggests lower financial risk, as it implies that a smaller portion of the company's assets is funded by debt obligations.

Bio-Rad Laboratories Inc.'s consistent debt-to-assets ratio around 0.10 indicates that the company has maintained a prudent level of debt relative to its total assets. This suggests a healthy balance between debt and equity financing, which could be viewed positively by investors and creditors.

The slight increase in the debt-to-assets ratio from 0.09 in Q1 2023 to 0.10 in Q4 2023 may indicate a slightly higher reliance on debt financing during that period. However, since the ratio remains within a narrow range, it does not raise significant concerns about the company's overall solvency or financial stability.

Overall, based on the historical trend of Bio-Rad Laboratories Inc.'s debt-to-assets ratio, the company appears to have a conservative approach to debt management, which may contribute to its financial resilience and long-term sustainability.